Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Stage”

3,066 trials

Showing 20 of 3,066 results

Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Early research (Phase 1)Looking for participantsNCT07174063
What this trial is testing

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 15
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Early research (Phase 1)Looking for participantsNCT06257693
What this trial is testing

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Alessa Therapeutics Inc. 56
Large-scale testing (Phase 3)Study completedNCT00626431
What this trial is testing

Leuprolide to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Abbott 310
Early research (Phase 1)Study completedNCT04702737
What this trial is testing

AMG 757 in Participants With Neuroendocrine Prostate Cancer

Who this might be right for
Neuroendocrine Prostate Cancer
Amgen 41
Testing effectiveness (Phase 2)Study completedNCT00661492
What this trial is testing

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Who this might be right for
Androgen-independent Prostate Cancer
US Oncology Research 115
Early research (Phase 1)Ended earlyNCT01262664
What this trial is testing

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Early research (Phase 1)Active Not RecruitingNCT04898634
What this trial is testing

JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 216
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07230106
What this trial is testing

SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 218
Large-scale testing (Phase 3)Not Yet RecruitingNCT06768255
What this trial is testing

Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC

Who this might be right for
Abiraterone AcetateMCRPC (metastatic Castration-resistant Prostate Cancer)
Ding-Wei Ye 400
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Ended earlyNCT04740034
What this trial is testing

AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 42
Testing effectiveness (Phase 2)Study completedNCT00243048
What this trial is testing

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 70
Testing effectiveness (Phase 2)UnknownNCT05286840
What this trial is testing

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Luke Nordquist, MD 150
Early research (Phase 1)Study completedNCT00582140
What this trial is testing

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 22
Early research (Phase 1)Ended earlyNCT03137758
What this trial is testing

A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals, Inc 12
Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05367440
What this trial is testing

Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 174
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation